FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Discover what star athletes and actors on Zepbound, Mounjaro, Ozempic, and Wegovy have to say about their experiences on these game-changing medications.

The SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already taking metformin. The primary aim was ...

Slimming injections cannot be sold or purchased in Hong Kong without doctor's prescription, but some retailers are operating grey market Online retailers and a Hong Kong pharmacy are offering slimming ...

More than a third of people in the West Midlands who use private weight loss injections say the cost has pushed them into ...

Three suspects allegedly attacked a delivery driver as he was dropping off medication for the pharmacy and stole two boxes containing GLP-1 weight loss drugs ...

If you’ve been researching quick weight loss options, you’ve probably heard about Mounjaro. It’s become a popular medication in Nigeria, and for good reason. The results people are seeing are ...

A woman who lost over four stone by taking Mounjaro said she will now have to stay on the weight loss medication for life – after piling the pounds back on after trying to live without it. Kelly ...

Mounjaro (tirzepatide) is a prescription drug for adults and certain children with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...

Eli Lilly & Co slashed the price of its blockbuster weight-loss and diabetes drug Mounjaro in China, intensifying competition with Novo Nordisk A/S and local rivals. A month’s supply of the lowest ...

Shares of Eli Lilly and Co. slumped toward their biggest selloff in more than three years on Wednesday, after the drugmaker reported third-quarter results that missed expectations, due to big misses ...